About the Scheme

The Scheme for "Promotion of Research and Innovation in Pharma MedTech sector (PRIP)" has been launched by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, with the goal of transforming India into a global powerhouse for R&D in the Pharma MedTech sector. The scheme has a total financial outlay of Rs 5000 crores, which includes Rs 700 crores to establish Centers of Excellence (CoEs) at seven National Institutes of Pharmaceutical Education & Research (NIPERs), and Rs 4250 crores to accelerate investments in the R&D ecosystem within the sector.

Enable Rapid Discovery, Development and Commercialization of Drugs

Enable Innovation in Medical Devices

Promote Industry-Academia collaboration

Cost based to Innovation driven growth

Key Documents

Gazette Notification

Operational Guidelines

Expression of Interest (EoI)

Frequently Asked Questions (FAQs)

Funding Categories

Industry-Academia Collaboration (B-I)

Pharma / MedTech companies in partnership with Government Institutes of National Repute
Upto Rs 125 Cr/project or 35% of the project cost, whichever lesser
Innovation Stages: Ideation to Commercialization and post market studies (TRL 1 to 9)

Lab to Market Transition (B-II)

Pharma & MedTech companies
Upto Rs 100 Cr/project or 35% of the project cost, whichever lesser
Innovation Stages: Early-Stage Validation to Commercialization (TRL 5 to 9)